Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 105446

In scope icon M 7 E
QID 105446 (Type "105446" in App Search)
A 3-month-old boy is brought to the pediatrician by his mother for evaluation of a facial rash that she noticed 3 days prior. He has a history of eczema that has been managed with topical emollients. He has been itching his face more than usual and the rash has changed in size and appearance from his normal eczematous rash. Today, he has appeared more tired than usual, has been difficult to console, and has had decreased oral intake. He attends daycare but has not had any sick contacts. His temperature is 102°F (38.9°C), blood pressure is 90/65 mmHg, pulse is 120/min, and respirations are 26/min. He is crying and appears irritable. On exam, there is a red, vesicular rash across the face and trunk as shown in Figure A. Which of the following is the most appropriate next step in management?
  • A

Cefazolin

39%

26/66

Clindamycin

2%

1/66

Acyclovir

3%

2/66

Supportive care and isolation

15%

10/66

Topical mupirocin

38%

25/66

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This infant with a history of eczema, fever, irritability, malaise, and a disseminated monomorphic vesicular rash most likely has eczema herpeticum, for which the treatment is acyclovir.

Eczema herpeticum is a potentially life-threatening rash caused by infection with herpes simplex virus (HSV) in the setting of an impaired skin barrier (such as eczema). It classically presents as a red, vesicular rash. There are often "punched out" erosions and associated crusting that give the rash its characteristic appearance. Although it can occur in any age group, this condition is particularly life-threatening in infants, who already have a relatively weak immune system. Complications include herpes keratoconjunctivitis, herpes encephalitis, and viremia. Acyclovir treats the infection and prevents complications. While mild cases may be managed with oral acyclovir, more severe cases or those with an immunocompromised state require intravenous therapy. Patients will often require hospital admission with additional supportive care.

Xiao et. al review the clinical manifestations, diagnosis and management of eczema herpeticum. They note the association of the disease with atopic dermatitis. They recommend treatment with acyclovir and state that while mild cases may be managed with oral acyclovir, moderate to severe cases require intravenous acyclovir.

Figure A shows an infant with a red, vesicular monomorphic rash across the face, with associated erosions and crusting, consistent with eczema herpeticum.

Incorrect answers:
Answer 1: Cefazolin may be used to treat cellulitis. Cellulitis is less common in this patient's age group. The appearance of this patient's rash in conjunction with a history of atopic dermatitis are more strongly suggestive of eczema herpeticum.

Answer 2: Clindamycin may be used to treat bacterial skin and soft tissue infections. It offers coverage for MRSA.

Answer 4: In an infant with with a rash due to a simple viral exanthem such as roseola, supportive care and isolation would be appropriate.

Answer 5: Topical mupirocin may be used for the management of impetigo. Impetigo may also appear as a facial rash with crusting. A disseminated rash with systemic signs such as fever would be unusual in impetigo.

Bullet Summary:
Eczema herpeticum is a potentially life-threatening manifestation of herpes simplex virus infection and is managed with acyclovir.

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

3.8

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(6)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options